Phospholipid metabolism in lung surfactant.
Pulmonary surfactant is a mixture of lipids, mostly phospholipids, and proteins that allows for breathing with minimal effort. The current chapter discusses the metabolism of the phospholipids of this material. Surfactant phospholipids are synthesized in the type II epithelial cells of the lung. The lipids and surfactant proteins are assembled in intracellular storage organelles, called lamellar bodies, and are subsequently secreted into the alveolar space. Within this extracellular space surfactant undergoes several transformations. First the lamellar bodies unravel to form a highly organized lattice-like lipid:protein structure tubular myelin. Second, the organized structures, in particular tubular myelin, adsorb to form a lipid at the air-liquid interface of the alveoli. It is, in fact, this surface tension reducing film that is responsible for the physiological role of surfactant, to prevent lung collapse and allow ease of inflation. Third, the surface film is converted to a small vesicular form. Finally, these small vesicles are taken-up by the type II cells for recycling and degradation and by alveolar macrophages for degradation.
Veldhuizen
Ruud
R
Departments of Medicine and Physiology and Pharmacology, Lawson Health Research Institute, London, ON, N6A 4V2, Canada.
Possmayer
Fred
F
D000368:Aged; D006801:Humans; D009186:Myelin Sheath / Q000648:ultrastructure; D010743:Phospholipids / Q000737:chemistry / Q000378:metabolism*; D011663:Pulmonary Surfactants / Q000737:chemistry* / Q000378:metabolism*; D015656:Respiratory Mechanics
D010743:Phospholipids; D011663:Pulmonary Surfactants